×

CellRapeutics™ Serum from Ocular Myasthenia Gravis Donor (XS-0426-XU152)

Online Inquiry  Datasheet

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

Sourced from donors whose symptoms are localized to the extraocular muscles, this serum provides a specialized medium for studying low-titer acetylcholine receptor or MuSK autoantibodies. It is a critical tool for researchers exploring why certain humoral responses remain restricted to ocular tissues and for developing more sensitive diagnostic assays for early-stage neuromuscular junction disorders.

Specific Inquiry

  • Size:
  Add to Cart

Donor Information

  • Product Name
  • CellRapeutics™ Serum from Ocular Myasthenia Gravis Donor
  • Cat. No.
  • XS-0426-XU152
  • Donor Age
  • Young Adult, Senior
  • Donor Health
  • Diagnosed with Myasthenia Gravis restricted to ocular muscles. Serum contains specific autoantibodies but typically lacks the broader systemic inflammatory intensity seen in generalized forms.
  • Ethnicity
  • Diverse backgrounds available.
  • Anticoagulant
  • None (separated via centrifugation following natural coagulation).
  • Additional Donor Information
  • Each lot features serum from donors with MG restricted to ocular symptoms. Profiles include AChR-antibody titers, clinical duration of ocular confinement, and history of acetylcholinesterase inhibitors.
  • Clinical Profile
  • Duration of ocular-only symptoms, AChR antibody titer, and history of conversion to generalized MG.

Additional Information

  • Medication History
  • Available upon request. Documentation of Pyridostigmine, low-dose corticosteroids, and any history of transition to systemic immunosuppressive therapy.
  • Formulation
  • Frozen
  • Cell Viability
  • Cell-free (no residual erythrocytes or leukocytes).
  • Mycoplasma Testing
  • Negative
  • Sterility Testing
  • Negative
  • Application
  • Drug Discovery, Immuno-oncology Research
  • Research Use Only
  • RUO
  • Quality Control
  • Each serum batch undergoes rigorous IRB-compliant screening, ensuring pathogen-free safety, consistent physicochemical properties, and standardized clinical characterization of disease-specific biomarkers to provide a reliable, high-purity biological matrix.
  • Storage
  • Store at -80°C or below for long-term stability, or at -20°C for up to 6 months, avoid repeated freeze-thaw cycles to preserve product quality.
  • Shiping
  • Dry Ice
  • Handling Notes
  • Thaw slowly on ice or at 4°C and centrifuge to remove cryoprecipitates, immediate aliquoting upon first thaw is recommended to maintain autoantibody functional integrity.
  • Warnings
  • Treat as potentially biohazardous human-derived material and handle strictly under BSL-2 guidelines using appropriate personal protective equipment.
  • Size
  • 1ML
  • Keywords
  • CellRapeutics™ Serum from Ocular Myasthenia Gravis Donor, Serum, Ocular Myasthenia Gravis

Case Studies

Customer Reviews and Q&As

There are currently no customer reviews or questions for CellRapeutics™ Serum from Ocular Myasthenia Gravis Donor (XS-0426-XU152). Click the button below to contact us or submit your feedback about this product.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Related Products

Immune Cell Products

T Cell Products

B Cell Products

PBMC Products

Monocyte Products

Dendritic Cell Products

Neutrophil Products

Online Inquiry
Products
Global Services. (Creative Biolabs Authorized)
Online Inquiry

For any technical issues or product/service related questions, please leave your information below. Our team will contact you soon.

Key Updates
Newsletter. (Creative Biolabs Authorized) NEWSLETTER

The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders

LEARN MORE NEWSLETTER
New Solution. (Creative Biolabs Authorized) NEW SOLUTION

CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.

LEARN MORE SOLUTION
Novel Solution. (Creative Biolabs Authorized) NOVEL TECHNOLOGY

Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.

LEARN MORE NOVEL TECHNOLOGY
New Technology. (Creative Biolabs Authorized) NEW SOLUTION

Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.

LEARN MORE SOLUTION
Receive our latest news and insights.
Copyright © 2026 Creative Biolabs. All Rights Reserved
  • 0
  • 0
Cart
    Go to checkout